Back to 
NORTHERN TRUST CORP
NORTHERN TRUST CORP
VIVO
Showing 0 of 17 quarters
Position history for NORTHERN TRUST CORP's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Northern Trust held 551,260 shares of VIVO (Meridian Bioscience), worth $18.3M. Northern Trust's 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.